|
(2S,4R)-1-acetyl-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-4-hydroxypyrrolidine-2-carboxamide
|
DB02812 |
|
|
N-(2-Acetamido)Iminodiacetic Acid
|
DB02810 |
|
|
Avexitide
|
DB14806 |
[Avexitide is under investigation in clinical trial NCT02996812 (Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia).] |
|
DCFPyL F-18
|
DB14805 |
[DCFPyL F-18 is under investigation in clinical trial NCT02691169 (Integrated 18F-labelled PSMA Project).] |
|
Lumicitabine
|
DB14808 |
[Lumicitabine is under investigation in clinical trial NCT03010059 (A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations).] |
|
Demplatin pegraglumer
|
DB14807 |
[Demplatin pegraglumer is under investigation in clinical trial NCT02043288 (Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer).] |
|
ONO-2952
|
DB14802 |
[ONO-2952 is under investigation in clinical trial NCT01887002 (Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)).] |
|
Lanifibranor
|
DB14801 |
[Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337).] |
|
Iodine I-125
|
DB14804 |
[Iodine I-125 is under investigation in clinical trial NCT00079417 (Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma).] |
|
AMY-101
|
DB14803 |
[AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis).] |
|
GP-100 antigen
|
DB14800 |
[GP-100 antigen is under investigation in clinical trial NCT00006385 (Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma).] |
|
Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester
|
DB02819 |
|
|
5-Fluorolevulinic Acid
|
DB02828 |
|
|
4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid
|
DB02829 |
|
|
7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid
|
DB02827 |
|
|
N-Pyridoxyl-Glycine-5-Monophosphate
|
DB02824 |
|
|
Methylphosphinate
|
DB02825 |
|
|
Para-Bromobenzyl Alcohol
|
DB02822 |
|
|
Phosphonoacetic Acid
|
DB02823 |
[A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent. [PubChem]] |
|
1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct
|
DB02820 |
|
